ARCHIVES

FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint.

This article is from The Cancer Letter archive.

Vol. 32 No. 28 | July 21, 2006

Download PDF Visit The Full Archive

Related Articles

Phase 1 AIDS Vaccine Trial Will Involve 81 Persons At NIH

August 28, 1987

In Brief: Voters Support Increase In Research Funds, Poll Finds; Baynes Heads BMT Unit In Detroit

February 28, 1997

Firm’s Information System Embedded In iKnowMed For Treatment Outcomes.

June 29, 2001

Conversation With The Cancer Letter: Ronald DePinho Says Moon Shots Will Go On

January 18, 2013

Advisors Urge NCI To Support Basic Chemoprevention.

January 7, 2000

Competition Developing For Three New Regional Cooperative Group Awards; RFA Within Two Months

December 12, 1980